Literature DB >> 30108856

Assessing the performance of docking scoring function, FEP, MM-GBSA, and QM/MM-GBSA approaches on a series of PLK1 inhibitors.

Chunlan Pu1, Guoyi Yan1, Jianyou Shi2, Rui Li1.   

Abstract

Over-expressed polo-like kinases 1, a key regulator of cell mitosis, is associated with carcinogenesis and poor prognosis. It is very necessary to develop a reliable computational affinity prediction protocol targeting PLK1. In this study, the performance of different docking scoring function, free energy perturbation, MM-GBSA and QM/MM-GBSA were evaluated. The ranking capability of FEP is the best with rs = 0.854. However, the rs obtained from MM-GBSA can reach 0.767, which requires only about one-eighth of the simulation time of FEP. As for the sampling method, single long molecular dynamics (SLMD) surpass the multiple short molecular dynamics (MSMD) in ranking of the 20 congeneric compounds by about 0.1 in rs. In addition, ligands treated by QM can significantly improve the ranking performance. As for the docking scoring functions, a force field-based scoring function is more suitable for ranking congeneric compounds.

Entities:  

Year:  2017        PMID: 30108856      PMCID: PMC6072424          DOI: 10.1039/c7md00184c

Source DB:  PubMed          Journal:  Medchemcomm        ISSN: 2040-2503            Impact factor:   3.597


  28 in total

1.  Rescoring docking hit lists for model cavity sites: predictions and experimental testing.

Authors:  Alan P Graves; Devleena M Shivakumar; Sarah E Boyce; Matthew P Jacobson; David A Case; Brian K Shoichet
Journal:  J Mol Biol       Date:  2008-01-30       Impact factor: 5.469

2.  Assessing the performance of MM/PBSA and MM/GBSA methods. 3. The impact of force fields and ligand charge models.

Authors:  Lei Xu; Huiyong Sun; Youyong Li; Junmei Wang; Tingjun Hou
Journal:  J Phys Chem B       Date:  2013-07-08       Impact factor: 2.991

3.  Effect of RNA silencing of polo-like kinase-1 (PLK1) on apoptosis and spindle formation in human cancer cells.

Authors:  Birgit Spänkuch-Schmitt; Jürgen Bereiter-Hahn; Manfred Kaufmann; Klaus Strebhardt
Journal:  J Natl Cancer Inst       Date:  2002-12-18       Impact factor: 13.506

4.  Development and validation of a genetic algorithm for flexible docking.

Authors:  G Jones; P Willett; R C Glen; A R Leach; R Taylor
Journal:  J Mol Biol       Date:  1997-04-04       Impact factor: 5.469

5.  ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent.

Authors:  Kiranmai Gumireddy; M V Ramana Reddy; Stephen C Cosenza; R Boominathan; R Boomi Nathan; Stacey J Baker; Nabisa Papathi; Jiandong Jiang; James Holland; E Premkumar Reddy
Journal:  Cancer Cell       Date:  2005-03       Impact factor: 31.743

6.  Polo-like kinase isoforms in breast cancer: expression patterns and prognostic implications.

Authors:  Wilko Weichert; Glen Kristiansen; Klaus-Jürgen Winzer; Mathias Schmidt; Volker Gekeler; Aurelia Noske; Berit-Maria Müller; Silvia Niesporek; Manfred Dietel; Carsten Denkert
Journal:  Virchows Arch       Date:  2005-03-23       Impact factor: 4.064

7.  Use of a QM/MM-based FEP method to evaluate the anomalous hydration behavior of simple alkyl amines and amides: application to the design of FBPase inhibitors for the treatment of type-2 diabetes.

Authors:  M Rami Reddy; U Chandra Singh; Mark D Erion
Journal:  J Am Chem Soc       Date:  2011-05-05       Impact factor: 15.419

Review 8.  Polo-like kinases (Plks) and cancer.

Authors:  Noriyuki Takai; Ryoji Hamanaka; Jun Yoshimatsu; Isao Miyakawa
Journal:  Oncogene       Date:  2005-01-10       Impact factor: 9.867

9.  Polo-like kinase-1 controls recovery from a G2 DNA damage-induced arrest in mammalian cells.

Authors:  Marcel A T M van Vugt; Alexandra Brás; René H Medema
Journal:  Mol Cell       Date:  2004-09-10       Impact factor: 17.970

10.  Antibody microinjection reveals an essential role for human polo-like kinase 1 (Plk1) in the functional maturation of mitotic centrosomes.

Authors:  H A Lane; E A Nigg
Journal:  J Cell Biol       Date:  1996-12       Impact factor: 10.539

View more
  6 in total

Review 1.  Computational Structure Prediction for Antibody-Antigen Complexes From Hydrogen-Deuterium Exchange Mass Spectrometry: Challenges and Outlook.

Authors:  Minh H Tran; Clara T Schoeder; Kevin L Schey; Jens Meiler
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

2.  Computational Investigations on the Natural Small Molecule as an Inhibitor of Programmed Death Ligand 1 for Cancer Immunotherapy.

Authors:  Geethu S Kumar; Mahmoud Moustafa; Amaresh Kumar Sahoo; Petr Malý; Shiv Bharadwaj
Journal:  Life (Basel)       Date:  2022-04-29

Review 3.  Molecular Docking: Shifting Paradigms in Drug Discovery.

Authors:  Luca Pinzi; Giulio Rastelli
Journal:  Int J Mol Sci       Date:  2019-09-04       Impact factor: 5.923

Review 4.  Application of MM-PBSA Methods in Virtual Screening.

Authors:  Giulio Poli; Carlotta Granchi; Flavio Rizzolio; Tiziano Tuccinardi
Journal:  Molecules       Date:  2020-04-23       Impact factor: 4.411

5.  Molecular docking-based computational platform for high-throughput virtual screening.

Authors:  Baohua Zhang; Hui Li; Kunqian Yu; Zhong Jin
Journal:  CCF Trans High Perform Comput       Date:  2022-01-13

6.  Modeling receptor flexibility in the structure-based design of KRASG12C inhibitors.

Authors:  Kai Zhu; Cui Li; Kingsley Y Wu; Christopher Mohr; Xun Li; Brian Lanman
Journal:  J Comput Aided Mol Des       Date:  2022-08-05       Impact factor: 4.179

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.